|
AU2016267579A1
|
|
Use of encapsulated cell therapy for treatment of ophthalmic disorders
|
|
KR20160086819A
|
|
Encapsulated cell therapy cartridge
|
|
US2015150796A1
|
|
Cryopreserved Implantable Cell Culture Devices and Uses Thereof
|
|
KR20140091651A
|
|
Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
|
|
EP2486128A1
|
|
Use of pedf in an encapsulated cell-based delivery system
|
|
WO2010123994A1
|
|
Cell lines that produce prostaglandin f2 alpha (pgf2a) and uses thereof
|
|
US2009269389A1
|
|
ARPE-19 as a Platform Cell Line for Encapsulated Cell-Based Delivery
|
|
US2007154524A1
|
|
Micronized device for the delivery of biologically active molecules and methods of use thereof
|
